Berjame, Angelita R.

HRN: 17-64-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/07/2023
09/14/2023
IV
600mg
Q6hours
Necrotic Breast Mass
Waiting Final Action 
09/07/2023
CEFTRIAXONE 1G (VIAL)
09/07/2023
09/13/2023
IVT
2g
OD
Ulcerated Breast Mass L; Complicated UTI
Waiting Final Action 
09/08/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/08/2023
09/16/2023
IV
1.5gm
TID
Infeceted Breast Mass
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: